These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12508937)

  • 1. Antioxidants and bone turnover in involutional osteoporosis.
    Maggio D; Barabani M; Pierandrei M; Macchiarulo MC; Cecchetti R; Pedrazzoni M; Senin U; Cherubini A
    J Endocrinol Invest; 2002; 25(10 Suppl):101-2. PubMed ID: 12508937
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.
    Boonen S; Marin F; Mellstrom D; Xie L; Desaiah D; Krege JH; Rosen CJ
    J Am Geriatr Soc; 2006 May; 54(5):782-9. PubMed ID: 16696744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
    Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF
    Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prolidase activity in postmenopausal osteoporosis.
    Namiduru ES; Binnur Erbagci A; Celik A; Yilmaz M; Tarakçioglu M
    Minerva Med; 2007 Dec; 98(6):647-51. PubMed ID: 18299678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements.
    Akin O; Göl K; Aktürk M; Erkaya S
    Gynecol Endocrinol; 2003 Feb; 17(1):19-29. PubMed ID: 12724015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of involutional bone loss: methodological and conceptual problems.
    Adami S; Kanis JA
    J Bone Miner Res; 1995 Apr; 10(4):511-7. PubMed ID: 7610920
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone remodeling].
    Lerner UH; Ljunggren O
    Lakartidningen; 2006 Oct 4-10; 103(40):2972-5. PubMed ID: 17115661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women].
    Guo LJ; Luo XH; Wu XP; Xie H; Zhou HD; Zhang H; Cao XZ; Liao EY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):734-7. PubMed ID: 15949377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women.
    Pasco JA; Henry MJ; Wilkinson LK; Nicholson GC; Schneider HG; Kotowicz MA
    J Womens Health (Larchmt); 2006 Apr; 15(3):295-300. PubMed ID: 16620188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
    Rasheed A; Khurshid R; Aftab L
    J Ayub Med Coll Abbottabad; 2008; 20(1):48-51. PubMed ID: 19024185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of raloxifene and clodronate on bone density in postmenopausal osteoporotic women.
    D'Amelio P; Muratore M; Tinelli F; Tamone C; Cosentino L; Quarta E; Calcagnile F; Carlo Isaia G
    Int J Tissue React; 2003; 25(2):73-8. PubMed ID: 14518596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal osteoporosis and alendronate.
    Pérez-López FR
    Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men.
    Gonnelli S; Caffarelli C; Del Santo K; Cadirni A; Guerriero C; Lucani B; Franci B; Nuti R
    Calcif Tissue Int; 2008 Jul; 83(1):55-60. PubMed ID: 18563283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.